Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: Possible involvement of cyclooxygenase blockade and antioxidant activity

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 4, 2009, Pages 511-515

  Fontenele, Juvenia B ^a   Leal, L Kalyne A M ^a   Silveira, Edilberto R ^a   Felix, F Helder ^a   Bezerra Felipe, Cícero F ^a   Viana, Glauce S B ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Antiplatelet effects; Piper tuberculatum; Piplartine; Platelet aggregation

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ALKALOID; ARACHIDONIC ACID; ARGININE; COLLAGEN; NITRIC OXIDE SYNTHASE; PENTOXIFYLLINE; PIPLARTINE; PROSTAGLANDIN SYNTHASE; THROMBIN; TICLOPIDINE; UNCLASSIFIED DRUG; ANTIOXIDANT; PIPERIDONE DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANTICOAGULATION; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENTIATION; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; MEDICINAL PLANT; NONHUMAN; PIPER TUBERCULATUM; PLANT ROOT; THROMBOCYTE AGGREGATION; CHEMISTRY; DRUG EFFECT; DRUG INTERACTION; PIPERACEAE; THROMBOCYTE RICH PLASMA;

ADENOSINE DIPHOSPHATE; ANTIOXIDANTS; ARACHIDONIC ACID; COLLAGEN; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; HUMANS; PIPERACEAE; PIPERIDONES; PLANT ROOTS; PLATELET AGGREGATION; PLATELET-RICH PLASMA; THROMBIN;

EID: 66449110250     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp/61.04.0014     Document Type: Article

References (43)

1. Weller T et al. Fibrinogen receptor antagonists - a novel class of promising antithrombotics. Drugs Future 1994; 19: 461-476.
2. Munger MA, Hawkins DWJ. Atherothrombosis: epidemiology, pathophysiology, and prevention. J Am Pharm Assoc 2004; 44: S5-S12.
3. Srivastava KC, Mustafa T. Spices: antiplatelet activity and prostanoid metabolism. Prostaglandins Leukot Essent Fatty Acids 1989; 38: 255-266.
4. Teng CM, Ko FN. Antiplatelet agents isolated from medicinal plants. Res Comm Mol Pathol Pharmacol 1998; 102: 211-225.
5. Parmar VS et al. Phytochemistry of the genus Piper. Phytochemistry 1997; 46: 597-673.
6. Li RW et al. Anti-inflammatory activity of Chinese medicinal vine plants. J Ethnopharmacol 2003; 85: 61-67.
7. Potzernheim M et al. Chemical characterization of seven Piper species (Piperaceae) from Federal District, Brazil, based on volatile constituents. Braz J Med Plants 2006; 8: 10-12.
8. Stöhr JR et al. Constituents of Chinese Piper species and their inhibitory activity on prostaglandin and leukotriene biosynthesis in vitro. J Ethnopharmacol 2001; 75: 133-139
9. Navickiene HM et al. Antifungal amides from Piper hispidum and Piper tuberculatum. Phytochemistry 2000; 55: 621-626.
10. Pio Correa M. Dicionário das Plantas Úteis do Brasil e das Exóticas Cultivadas, vol. 5, Rio de Janeiro: Ministério da Agricultura, 1984: 478.
11. Braga R. Plantas do Nordeste, Especialmente do Ceara, 2nd edn. Ed. Universitária-UFRN, Natal, Brazil, 1960.
12. Araújo-Júnior JX et al. Cepharanone B from Piper tuberculatum. Biochem. Sys Ecol 1999; 27: 325-327.
13. Leitão-da-Cunha EV, Chaves COM. Two amides from Piper tuberculatum fruits. Fitoterapia 2001; 72: 197-199.
14. Braz-Filho R et al. Piplartine-dimer A, a new alkaloid from Piper tuberculatum. Phytochemistry 1981; 20: 345-346.
15. Wu QL, Feng YX. Lignans from Piper genus (Piperaceae) and their bioactivity. World Notes on Plant Medicine 1994; 9: 51-56.
16. Duh CY et al. Cytotoxic pyridone alkaloids from the leaves of Piper aborescens. J Nat Prod 1990; 53: 1575-1577.
17. Zeng HW et al. Piperbetol, methylpiuperbetol, piperol A, piperol B: a new series of highly specific PAF receptor antagonists from Piper betle. Planta Med 1997; 63: 296-298.
18. Bezerra DP et al. Antiproliferative effects of two amides, piperine and piplartine from Piper species. Z Naturforsch [C] 2005; 60: 539-543.
19. Jatan I et al. Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants. Phytomedicine 2005; 12: 88-92.
20. Tsai IL et al. New cyclobutanoid amides, a new furanoid lignan and anti-platelet aggregation constituents from Piper arborescens. Planta Med 2005; 71: 535-542.
21. Lei D et al. Antioxidant and antiplatelet effects of aqueous inflorescence Piper betle extract. J Agric Food Chem 2003; 51: 2083-2088.
22. Jeng JH et al. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of oxygen species and cyclooxygenase. Free Radic Biol Med 2002; 32: 860-871.
23. Atal CK et al. The chemistry of Indian Piper species. Lloydia 1975; 38: 256-264.
24. Brecher G, Cronkite EP. Morphology and enumeration of human blood platelets. J Appl Physiol 1950; 3: 365-372.
25. Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168: 178-195.
26. Maurice DH, Haslam RJ. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol 1990; 37: 671-681.
27. Kang WS et al. Antithrombotic activities of green tea catechins and (2)-epigallocatechin gallate. Thromb Res 1999; 96: 229-237.
28. Soslau G et al. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 2001; 276: 21173-21183.
29. Hechler B et al. The P2 receptors in platelet function. Semin Thromb Haemost 2005; 31: 150-161.
30. Gachet C et al. The platelet P2 receptors in arterial thrombosis. Blood Cells Mol Dis 2006; 36: 223-227.
31. Savi P et al. Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett 1998; 422: 291-295.
32. Conley PB, Delaney SM. Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis. Curr Opin Hematol 2003; 10: 333-338.
33. Murugappa S, Kunapuli SP. The role of ADP receptors in platelet function. Front Biosc 2006; 11: 1977-1986.
34. Cattaneo M et al. Platelets from a patient heterozygous for the defect of P2CYC receptors forADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors. Arterioscler Thromb Vasc Biol 2000; 20: E101-E106.
35. Ohkubo S et al. Thromboxane A2 stimulates mitogen-activated protein kinase and arachidonic acid liberation in rabbit platelets. Prostaglandins 1996; 52: 403-413
36. Kulmacs RS et al. Heme spin states and peroxide induced radical species in prostaglandin H synthase. J Biol Chem 1987; 262: 10524-10531.
37. 2-dependent platelet activation. Platelets 1992; 2: 87-90.
38. Del Príncipe D et al. Hydrogen peroxide has a role in the aggregation of human platelets. FEBS Lett 1985; 185: 142-146.
39. Kimlough-Rathbone RL et al. Mechanism of platelet shape change, aggregation and release induced by collage, thrombin or A23187. J Lab Clin Med 1977; 90: 707-712.
40. Pignatelli P et al. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 1998; 91: 484-490.
41. Caccese D et al. Superoxide anion and hydroxy radical release by collagen-induced platelet aggregation: role of arachidonic acid metabolism. Thromb Haemost 2000; 83: 485-490.
42. Park BS et al. Antiplatelet activities of newly synthesized derivatives of piperlongumine. Phytother Res 2008; 22: 1195-1199.
43. IwashitaMet al. Piperlongumine, a constituent of Piper longumL., inhibits rabbit platelet aggregation as a thromboxane A(2) receptor antagonist. Eur J Pharmacol 2007; 570: 38-42.